Inventor · disambiguated record
Luke Masterson
Also filed as: MASTERSON LUKE
17 granted patents·12 pending applications·731 citations·filing 2004–2024
95Inventor score
Top patents by PatentIndex Score
29 records- 0198US8829184B2Intermediates useful for the synthesis of pyrrolobenzodiazepinesHOWARD PHILIP WILSON·Filed 2011·Granted Sep 9, 2014·63 cites·24 claims
- 0298US8697688B2Pyrrolobenzodiazepines used to treat proliferative diseasesHOWARD PHILIP WILSON·Filed 2011·Granted Apr 15, 2014·155 cites·7 claims
- 0398US8592576B2Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseasesHOWARD PHILIP WILSON·Filed 2009·Granted Nov 26, 2013·92 cites·42 claims
- 0498US7429658B2Synthesis of protected pyrrolobenzodiazepinesSPIROGEN LTD·Filed 2004·Granted Sep 30, 2008·137 cites·7 claims
- 0597US8940733B2Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseasesSPIROGEN SARL·Filed 2013·Granted Jan 27, 2015·66 cites·18 claims
- 0697US8501934B2PyrrolobenzodiazepinesHOWARD PHILIP WILSON·Filed 2009·Granted Aug 6, 2013·98 cites·18 claims
- 0797US8487092B2PyrrolobenzodiazepinesHOWARD PHILIP WILSON·Filed 2009·Granted Jul 16, 2013·68 cites·23 claims
- 0895US9624227B2Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseasesMEDIMMUNE LTD·Filed 2014·Granted Apr 18, 2017·26 cites·17 claims
- 0992US9732084B2Pyrrolobenzodiazepines used to treat proliferative diseasesMEDIMMUNE LTD·Filed 2013·Granted Aug 15, 2017·19 cites·19 claims
- 1089US11446292B2Compounds and conjugates thereofMEDIMMUNE LTD·Filed 2021·Granted Sep 20, 2022·2 cites·15 claims
- 1183US10533058B2Peptidomimetic compounds and antibody-drug conjugates thereofGENENTECH INC·Filed 2014·Granted Jan 14, 2020·2 cites·7 claims
- 1280US10695439B2Pyrrolobenzodiazepine conjugatesMEDIMMUNE LTD·Filed 2017·Granted Jun 30, 2020·1 cites·14 claims
- 1379US2022298161A1Pyrrolobenzodiazepines and conjugates thereofMEDIMMUNE LTD·Filed 2022·Application pending·0 cites
- 1476US11135303B2Pyrrolobenzodiazepines and conjugates thereofMEDIMMUNE LTD·Filed 2012·Granted Oct 5, 2021·1 cites·36 claims
- 1575US11517626B2Pyrrolobenzodiazepine antibody conjugatesMEDIMMUNE LTD·Filed 2017·Granted Dec 6, 2022·1 cites·13 claims
- 1664US2023143309A1Pyrrolobenzodiazepine antibody conjugatesMEDIMMUNE LTD·Filed 2022·Application pending·0 cites
- 1763US12337038B2Conjugates comprising cleavable beta-glucuronide-containing linkersASTRAZENECA AB·Filed 2024·Granted Jun 24, 2025·0 cites·26 claims
- 1863US11692043B2Peptidomimetic compounds and antibody-drug conjugates thereofGENENTECH INC·Filed 2019·Granted Jul 4, 2023·0 cites·6 claims
- 1963US2022211863A1Compounds and conjugates thereofMEDIMMUNE LTD·Filed 2020·Application pending·0 cites
- 2063US2020306243A1Compounds and conjugates thereofMEDIMMUNE LTD·Filed 2020·Application pending·0 cites
- 2158US2018134717A1Pyrrolobenzodiazepines and conjugates thereofMEDIMMUNE LTD·Filed 2017·Application pending·0 cites
- 2254US2013028917A1Pyrrolobenzodiazepines and conjugates thereofSPIROGEN DEVELOPMENTS SARL·Filed 2011·Application pending·0 cites
- 2354US2011256157A1Pyrrolobenzodiazepines and conjugates thereofSPIROGEN LTD·Filed 2011·Application pending·0 cites
- 2452US2021380605A1Pyrrolobenzodiazepine conjugatesMEDIMMUNE LTD·Filed 2019·Application pending·0 cites
- 2551US2014030279A1Anti-cd22 antibodies and immunoconjugatesSpirogen Sari·Filed 2013·Application pending·0 cites
- 2649US2020289660A1Pyrrolobenzodiazepine conjugatesMEDIMMUNE LTD·Filed 2018·Application pending·0 cites
- 2747US2017290920A1Anti-cd22 antibodies and immunoconjugatesMEDIMMUNE LTD·Filed 2017·Application pending·0 cites
- 2846US11649250B2Pyrrolobenzodiazepine conjugatesMEDIMMUNE LTD·Filed 2018·Granted May 16, 2023·0 cites·31 claims
- 2942US2021283141A1Pyrrolobenzodiazepine conjugatesMEDIMMUNE LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Luke Masterson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →